GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » INIFY Laboratories AB (OSL:INIFY) » Definitions » Total Payout Ratio

INIFY Laboratories AB (OSL:INIFY) Total Payout Ratio : 0.00 (As of Dec. 13, 2024)


View and export this data going back to 2022. Start your Free Trial

What is INIFY Laboratories AB Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

INIFY Laboratories AB's current Total Payout Ratio is 0.00.


INIFY Laboratories AB Total Payout Ratio Historical Data

The historical data trend for INIFY Laboratories AB's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

INIFY Laboratories AB Total Payout Ratio Chart

INIFY Laboratories AB Annual Data
Trend Dec21 Dec22 Dec23
Total Payout Ratio
- - -

INIFY Laboratories AB Quarterly Data
Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of INIFY Laboratories AB's Total Payout Ratio

For the Diagnostics & Research subindustry, INIFY Laboratories AB's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


INIFY Laboratories AB's Total Payout Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, INIFY Laboratories AB's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where INIFY Laboratories AB's Total Payout Ratio falls into.



INIFY Laboratories AB Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

INIFY Laboratories AB's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -54.842
=0.00

INIFY Laboratories AB's Total Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -12.365
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


INIFY Laboratories AB Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of INIFY Laboratories AB's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


INIFY Laboratories AB Business Description

Traded in Other Exchanges
N/A
Address
Scheeles vag 3, Solna, SWE, 171 65
INIFY Laboratories AB provides cancer diagnostics through ultra-modern laboratory services within pathology. It uses a fully digital, standardized, and AI-supported workflow to optimize quality and response times, initially within the prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer's organization.

INIFY Laboratories AB Headlines

No Headlines